ReviewChronic diseases and translational medicine2026

GLP-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease: Bridging Hepatic and Cardiovascular Outcomes.

Gabriel Amorim Moreira Alves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.